Ting Rao - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ting Rao

Showing results (111-120 of 113) with videos related to

Pageof 12

Sort By:

You have reached the last page of results.This site can display upto 113 results.

Journal for Immunotherapy of Cancer|November 2, 2021

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancerShaoming Zhu, A-Hong Ma, Zheng Zhu, et al.

JAMA Network Open|September 12, 2022

Association of Ethnicity, Sex, and Age With Cancer Diagnoses and Health Care Utilization Among Children in Inner Mongolia, ChinaHu-Zi-Wei Zhou, Li-Ying Qiao, Yun-Jing Zhang, et al.

JCI Insight|July 19, 2022

ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitorsHasibur Rehman, Darshan S Chandrashekar, Chakravarthi Balabhadrapatruni, et al.

Pageof 12

Search research articles

Showing results (111-120 of 113) with videos related to

Sort By:

Pageof 12

You have reached the last page of results.This site can display upto 113 results.

Journal for Immunotherapy of Cancer|November 2, 2021

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancerShaoming Zhu, A-Hong Ma, Zheng Zhu, et al.

JAMA Network Open|September 12, 2022

Association of Ethnicity, Sex, and Age With Cancer Diagnoses and Health Care Utilization Among Children in Inner Mongolia, ChinaHu-Zi-Wei Zhou, Li-Ying Qiao, Yun-Jing Zhang, et al.

JCI Insight|July 19, 2022

ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitorsHasibur Rehman, Darshan S Chandrashekar, Chakravarthi Balabhadrapatruni, et al.

Pageof 12